+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Anti Peptic Ulcer Drugs Markets in China

  • PDF Icon

    Report

  • 211 Pages
  • February 2024
  • Region: China
  • AMID Co
  • ID: 836813

China's demand for Anti Peptic Ulcer Drugs will continue to grow at about 7% by 2033

China's demand for Anti Peptic Ulcer Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2013, 2018 and 2023) and long-term forecasts through 2028 and 2033 are presented. Major producers in China are profiled.

The primary and secondary research is done in China in order to access up-to-date government regulations, market information and industry data. Data were collected from the Chinese government publications, Chinese language newspapers and magazines, industry associations, local governments’ industry bureaus, industry publications, and in-house databases. Interviews are conducted with Chinese industry experts, university professors, and producers in China. Economic models and quantitative methods are applied in this report to project market demand and industry trends. Metric system is used and values are presented in either Yuan (RMB, current price) and/or US dollars.

Table of Contents

I. INTRODUCTION
  • Report Scope and Methodology
  • Executive Summary
II. BUSINESS ENVIRONMENT
  • Economic Outlook
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor
  • Foreign Investment
  • Foreign Trade
  • Financial and Tax Regulations
  • Banking System and Regulations
  • Foreign Exchange
  • Taxes, Tariff and Custom Duties
III. ANTI PEPTIC ULCER DRUGS INDUSTRY ASSESSMENTS
  • Anti Peptic Ulcer Drugs Industry Structure
  • Market Size
  • Market Growth Drivers
  • Anti Peptic Ulcer Drugs Sales Volume
  • Major Producer Facility Locations
  • Major Producers’ Sales Volume and Market Share
  • Labor Cost
  • Potential Entrants
  • Major Distributors
  • Major Foreign Investment
  • Technology Development
IV. ANTI PEPTIC ULCER DRUGS PRODUCTION AND DEMAND
  • Market Overview by Drugs Classification
  • Proton Pump Inhibitor
  • H2 Receptor Antagonist
  • Gastric Mucosal Protective Drugs
  • Other Anti Peptic Ulcer Drugs
  • Import and Export
  • Market Overview by Producers
  • Pricing Trend
V. ANTI PEPTIC ULCER DRUGS MARKET OUTLOOK
  • Anti Peptic Ulcer Drugs Markets Outlook Overview
  • Government Regulations
  • Health Care Insurance Industry Overview
  • Consumer Spending Trends
  • Northeast
  • North
  • Southeast
  • Central
  • Southwest
  • Northwest
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
VI. MARKETING STRATEGIES
  • China Market Entry Overview
  • China’s Distribution System
  • Anti Peptic Ulcer Drugs Distribution Channels
  • Transportation and Freight Infrastructure
  • Communications
  • China’s Market Entry
  • Export to China
  • Indirect Export
  • Direct Export
  • License and Contract Manufacture
  • Assembling in China
  • Contract Manufacturing
  • Trade Permit
  • Investment
  • Equity Joint Venture
  • Contractual Joint Venture
  • Wholly Foreign-Owned Enterprise
VII. ANTI PEPTIC ULCER DRUGS PRODUCER DIRECTORY
  • Profiles of Anti Peptic Ulcer Drugs Producers and Major Consumption in Industry
LIST OF TABLES
I. INTRODUCTION
  • Economic Outlook Summary
II. BUSINESS ENVIRONMENT
  • Key Economic Indicators
  • Industrial Output
  • Population and Labor Force Trends
  • Foreign Investment and Loans
  • Foreign Trade
III. ANTI PEPTIC ULCER DRUGS INDUSTRY ASSESSMENTS
  • Anti Peptic Ulcer Drugs Sales Volume and Market Share by Drugs Classification
  • Proton Pump Inhibitors Sales Volume and Market Share by Drugs Classification
  • H2 Receptor Antagonist Sales Volume and Market Share by Drugs Classification
  • Gastric Mucosal Protective Drugs Sales Volume and Market Share by Drugs Classification
  • Anti Peptic Ulcer Drugs Sales Volume
  • Major Producer Facility Location
  • Major Anti Peptic Ulcer Drugs Producer Sales Volume
  • Major Foreign Investment in China
IV. ANTI PEPTIC ULCER DRUGS PRODUCTION AND DEMAND
  • Anti Peptic Ulcer Drugs Sales Volume by Drugs Classification
  • Anti Peptic Ulcer Drugs Market Share by Drugs Classification
  • Proton Pump Inhibitors Sales Volume and Market Share by Drugs Classification
  • H2 Receptor Antagonist Sales Volume and Market Share by Drugs Classification
  • Gastric Mucosal Protective Drugs Sales Volume and Market Share by Drugs Classification
  • Other Anti Peptic Ulcer Drugs Sales Volume and Market Share by Drugs Classification
  • Anti Peptic Ulcer Drugs Import by Drugs Classification
  • Anti Peptic Ulcer Drugs Import Market Share by Drugs Classification
  • Anti Peptic Ulcer Drugs Export by Drugs Classification
  • Anti Peptic Ulcer Drugs Export Market Share by Drugs Classification
  • Anti Peptic Ulcer Drugs Major Producer, Sales Volume, and Market Share
V. ANTI PEPTIC ULCER DRUGS MARKET OUTLOOK
  • Total Anti Peptic Ulcer Drugs Consumption
  • Consumer Spending Trend
  • The Structure of Per Capita Expenditure in the Northeast of China
  • The Structure of Per Capita Expenditure in the North of China
  • The Structure of Per Capita Expenditure in the Southeast of China
  • The Structure of Per Capita Expenditure in the Central of China
  • The Structure of Per Capita Expenditure in the Southwest of China
  • The Structure of Per Capita Expenditure in the Northwest of China
  • Demographic Trends
  • Health Care Industry Trends
  • Hospitals and Hospital Beds
LIST OF CHARTS
I. INTRODUCTION
  • Anti Peptic Ulcer Drugs Sales Volume
II. BUSINESS ENVIRONMENT
  • China’s GDP and Growth Rate
  • Industrial Output by Ownership
  • China’s Imports and Exports
III. ANTI PEPTIC ULCER DRUGS INDUSTRY ASSESSMENTS
  • Total Anti Peptic Ulcer Drugs Sales Volume
  • Anti Peptic Ulcer Drugs Sales Volume by Drugs Classification
  • Proton Pump Inhibitors Market Share by Drugs Classification
  • H2 Receptor Antagonist Market Share by Drugs Classification
  • Gastric Mucosal Protective Drugs Market Share by Drugs Classification
  • Anti Peptic Ulcer Drugs Sales Volume
IV. ANTI PEPTIC ULCER DRUGS PRODUCTION AND DEMAND
  • Anti Peptic Ulcer Drugs Sales Volume
  • Anti Peptic Ulcer Drugs Import
  • Anti Peptic Ulcer Drugs Export
  • Anti Peptic Ulcer Drugs Sales Volume by Drugs Classification
  • Proton Pump Inhibitors Sales Volume and Market Share
  • Proton Pump Inhibitors Market Share by Drugs Classification
  • H2 Receptor Antagonist Sales Volume and Market Share
  • H2 Receptor Antagonist Market Share by Drugs Classification
  • Gastric Mucosal Protective Drugs Sales Volume and Market Share
  • Gastric Mucosal Protective Drugs Market Share by Drugs Classification
  • Other Anti Peptic Ulcer Drugs Sales Volume and Market Share
  • Other Anti Peptic Ulcer Drugs Market Share by Drugs Classification
  • Anti Peptic Ulcer Drugs Import by Drugs Classification
  • Proton Pump Inhibitors Import by Drugs Classification
  • Proton Pump Inhibitors Import and Market Share
  • H2 Receptor Antagonist Import and Market Share
  • Gastric Mucosal Protective Drugs Import and Market Share
  • Other Anti Peptic Ulcer Drugs Import and Market Share
  • Anti Peptic Ulcer Drugs Export by Drugs Classification
  • Proton Pump Inhibitors Export and Market Share
  • Gastric Mucosal Protective Drugs Export and Market Share
  • H2 Receptor Antagonist Export and Market Share
  • Other Anti Peptic Ulcer Drugs Export and Market Share
V. ANTI PEPTIC ULCER DRUGS MARKET OUTLOOK
VI. MARKETING STRATEGIES
  • China’s Distribution Channel

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Changzhou Siyao Pharmaceutical Co. Ltd.
  • Nanjing Aosaikang Medicinal Group